1 – 10 of 64
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008–2021 from the Swedish myeloma registry
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma : Real-world evidence from Sweden
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern treatment
    
    - Contribution to journal › Article
 
- 
                        Mark
        Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens
    
    - Contribution to journal › Published meeting abstract
 
- 
                        Mark
        Neutrophils as Suppressor Cells and their role in Multiple Myeloma
    (2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Genetic predisposition for Multiple Myeloma. Identification and functional characterization of risk variants
    (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 
                        Mark
        Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group
    
    - Contribution to journal › Article
 
- 
                        Mark
        Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
    
    - Contribution to journal › Article
 
- 
                        Mark
        Genetic Predisposition to Sporadic and Familial Multiple Myeloma
    (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
